Spirox Obtains $45,000,000 Series C Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    3475 Edison Way Menlo Park, CA 94015 USA
  • Company Description
    Spirox is focused on developing minimally invasive technologies to improve the quality of life for patients with nasal obstruction.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Spirox, which is developing a novel, minimally invasive system to be used by Ear, Nose and Throat (ENT) physicians and plastic surgeons to treat patients with nasal obstruction, looks forward to partnering with KKR to help scale the business and better serve the greater ENT community.
  • M&A Terms
  • Venture Investor
  • Venture Investor
    HealthQuest Capital
  • Venture Investor
    Aisling Capital
  • Venture Investor
    Aperture Venture Partners
  • Venture Investor

Trending on Xconomy